Cash Flow

v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (8,315,000) $ (5,752,000)
Reconciliation of net loss to net cash used in operating activities    
Depreciation and ROU asset amortization 280,000 280,000
Amortization of intellectual property 18,000 45,000
Stock-based compensation 701,000 774,000
Change in fair value of warrant liability (491,000) (0)
Amortization of deferred financing costs 243,000 11,000
Impairment expense 5,247,000 0
Non-cash interest expense 74,000 24,000
Changes in operating assets and liabilities    
Accounts receivable (128,000) 67,000
Inventory 6,000 (111,000)
Prepaid expenses and other current assets (43,000) (115,000)
Accounts payable (136,000) 111,000
Accrued expenses (650,000) 399,000
Other assets and liabilities 441,000 16,000
Net cash used in operating activities (2,753,000) (4,251,000)
Cash flows from investing activities:    
Purchases of property, plant and equipment (289,000) (2,737,000)
Proceeds from note receivable 100,000 150,000
Equipment deposits (186,000) (2,992,000)
Net cash used in investing activities (375,000) (5,579,000)
Cash flows from financing activities:    
Principal payments on note payable (500,000) 0
Principal payments on finance leases (10,000) 0
Cash paid for tax withholdings on RSUs vesting (66,000) (360,000)
Debt issuance costs 0 (164,000)
Proceeds from ATM, net 1,214,000 2,126,000
Net cash provided by financing activities 638,000 1,602,000
Net decrease in cash and cash equivalents (2,490,000) (8,228,000)
Cash and cash equivalents at beginning of period 4,079,000 16,522,000
Cash and cash equivalents at end of period 1,589,000 8,294,000
Supplemental disclosure of cash flows information    
Cash paid for interest 86,000 82,000
Supplemental disclosure of non-cash transactions    
Acquisitions of property, plant and equipment included in accounts payable 181,000 1,121,000
Acquisitions of property, plant and equipment included in accrued expenses $ 0 $ 1,638,000

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL